We are live on ! Find out more
DM

Deerfield Management Portfolio holdings

AUM $8.48B
1-Year Est. Return 99.04%
This Fund
S&P 500
This Quarter Est. Return
-3.25%
1 Year Est. Return
+99.04%
3 Year Est. Return
+273.78%
5 Year Est. Return
+280.99%
10 Year Est. Return
+2,168.14%
AUM
$6.01B
AUM Growth
+$262M
Cap. Flow
-$162M
Cap. Flow %
-2.7%
Top 10 Hldgs %
51.52%
Holding
592
New
224
Increased
125
Reduced
42
Closed
159

Top Buys

Rank Stock Value
1
WAY
Waystar Holding Corp
WAY
+$107M
2
GILD icon
Gilead Sciences
GILD
+$99.5M
3
CVS icon
CVS Health
CVS
+$61M
4
BAX icon
Baxter International
BAX
+$57.9M
5
CGEM icon
Cullinan Oncology
CGEM
+$45.6M

Top Sells

Rank Stock Value
1
FUSN
Fusion Pharmaceuticals Inc. Common Shares
FUSN
+$136M
2
DCPH
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
+$80.7M
3
SWTX
SpringWorks Therapeutics
SWTX
+$63.2M
4
OSCR icon
Oscar Health
OSCR
+$44.4M
5
VKTX icon
Viking Therapeutics
VKTX
+$38M

Sector Composition

Rank Sector Weight
1 Healthcare 83.29%
2 Industrials 0.69%
3 Technology 0.57%
4 Financials 0.44%
5 Consumer Discretionary 0.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CAH icon
451
Cardinal Health
CAH
$53.7B
– –
-2,276
Closed -$255K
CASH icon
452
Pathward Financial
CASH
$1.82B
– –
-6,188
Closed -$312K
CCCC icon
453
C4 Therapeutics
CCCC
$397M
– –
-28,590
Closed -$234K
CERS icon
454
Cerus
CERS
$615M
– –
-59,637
Closed -$113K
CFLT
455
DELISTED
Confluent
CFLT
– –
-8,962
Closed -$274K
COLD icon
456
Americold
COLD
$4.17B
– –
-13,995
Closed -$349K
COLM icon
457
Columbia Sportswear
COLM
$3.25B
– –
-4,216
Closed -$342K
CPB icon
458
Campbell Soup
CPB
$6.67B
– –
-5,701
Closed -$253K
CRI icon
459
Carter's
CRI
$1.43B
– –
-3,743
Closed -$317K
CTVA icon
460
Corteva
CTVA
$58.6B
– –
-5,058
Closed -$292K
CUBI icon
461
Customers Bancorp
CUBI
$2.66B
– –
-4,297
Closed -$228K
DD icon
462
DuPont de Nemours
DD
$18.9B
– –
-4,000
Closed -$385K
DGX icon
463
Quest Diagnostics
DGX
$25.6B
– –
-2,157
Closed -$287K
DLX icon
464
Deluxe
DLX
$1.22B
– –
-17,885
Closed -$368K
DNA icon
465
Ginkgo Bioworks
DNA
$487M
– –
-874
Closed -$40.6K
DRS icon
466
Leonardo DRS
DRS
$12.9B
– –
-31,888
Closed -$704K
DYN icon
467
Dyne Therapeutics
DYN
$4.24B
– –
-7,940
Closed -$225K
EA icon
468
Electronic Arts
EA
$52.4B
– –
-6,602
Closed -$876K
ECL icon
469
Ecolab
ECL
$76.4B
– –
-1,107
Closed -$256K
ECVT icon
470
Ecovyst
ECVT
$1.34B
– –
-23,217
Closed -$259K
ED icon
471
Consolidated Edison
ED
$41.1B
– –
-3,275
Closed -$297K
EIG icon
472
Employers Holdings
EIG
$906M
– –
-11,427
Closed -$519K
ENGN icon
473
enGene Therapeutics
ENGN
$118M
– –
-800,000
Closed -$13.6M
ESAB icon
474
ESAB
ESAB
$5.49B
– –
-3,546
Closed -$392K
FCEL icon
475
FuelCell Energy
FCEL
$1.72B
– –
-2,588
Closed -$92.4K
17 18
19
20 21

Similar funds

FT
Fiduciary Trust Boston, Massachusetts $8.46B AUM 21.38% 1-Year Est. Return
GRQ
Gardner Russo & Quinn Lancaster, Pennsylvania $8.5B AUM 9.79% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
VA
Valmark Advisers Akron, Ohio $8.42B AUM 14.36% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $8.4B AUM 63.34% 1-Year Est. Return
IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
NW
NewEdge Wealth Pittsburgh, Pennsylvania $8.39B AUM 24.47% 1-Year Est. Return
AAF
Andra AP-fonden Goteborg, Sweden $8.39B AUM 21.19% 1-Year Est. Return

Deerfield Management's Q2 2024 Portfolio in Review

As of Q2 2024, Deerfield Management held 592 positions worth $6.01B, up 4.6% from $5.75B the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Deerfield Management's Q2 2024 filing shows 224 new, 125 increased, 42 reduced and 159 closed positions. Its largest new stake was Waystar Holding Corp: 4,952,004 shares worth $106M. The largest sale was Fusion Pharmaceuticals Inc. Common Shares, an estimated $136M.

By sector, the portfolio is most concentrated in Healthcare at 83% of assets, down from 89% a quarter earlier, followed by Industrials and Technology.

  • Deerfield Management's largest Q2 2024 buy was Waystar Holding Corp: 4,952,004 shares worth $106M.
  • Deerfield Management added most to Baxter International in Q2 2024, an estimated $57.9M increase.
  • Deerfield Management's biggest Q2 2024 reduction was Oscar Health, cutting an estimated $44.4M.
  • Deerfield Management fully exited Fusion Pharmaceuticals Inc. Common Shares in Q2 2024, selling an estimated $136M.
  • Deerfield Management's ten largest holdings make up 52% of its $6.01B portfolio in Q2 2024.
  • Deerfield Management opened 224 new positions and closed 159 in Q2 2024.
  • Deerfield Management's portfolio value rose 4.6% quarter-over-quarter to $6.01B.

Based on Deerfield Management's 13F filing for Q2 2024, filed 14 Aug 2024.